A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
Public ClinicalTrials.gov record NCT00316602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label, Controlled Phase II Study to Evaluate Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in 18-40 Year Old Subjects With Diagnosed Atopic Dermatitis
Study identification
- NCT ID
- NCT00316602
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bavarian Nordic
- Industry
- Enrollment
- 632 participants
Conditions and interventions
Conditions
Interventions
- IMVAMUNE Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2006
- Primary completion
- Oct 31, 2009
- Completion
- Mar 31, 2010
- Last update posted
- Jan 8, 2019
2006 – 2010
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alta Clinical Research LLC | Tucson | Arizona | 85745 | — |
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Rx Clinical Research, Inc. | Garden Grove | California | 92843 | — |
| Solano Clinical Research | Vallejo | California | 94589 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Adult & Pediatric Dermatology PC | Overland Park | Kansas | 66211 | — |
| University of Kentucky Medical Center | Lexington | Kentucky | 40536-0093 | — |
| Saint Louis University | St Louis | Missouri | 63104 | — |
| Sundance Clinical Research | St Louis | Missouri | 63141 | — |
| Meridian Clinical Research | Omaha | Nebraska | 68134 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106-5239 | — |
| Dermatology Associates of Rochester | Rochester | New York | 14623 | — |
| Oregon Dermatology & Research Center | Portland | Oregon | 97210 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | — |
| Dermatology Clinical Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00316602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00316602 live on ClinicalTrials.gov.